XOMA Royalty Corp. (XOMA)

33.35 +2.86 (+9.38%) USD  |  NASDAQ  |  Dec 09, 10:09
More

XOMA Royalty EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for XOMA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
Vistagen Therapeutics, Inc. Upgrade
Zevra Therapeutics, Inc. Upgrade
Tango Therapeutics, Inc. --
NovaBay Pharmaceuticals, Inc. Upgrade
Palatin Technologies, Inc. Upgrade